logo
Select company
Select metric
-90.62%Return on Equity
VS
Market
12
Sector
33
Industry
42
History
21
$ 0.51Close
$ 0.25 - $ 1.2 52-Week Range
Ticker Information

Ticker

RLYB

Company Name

RALLYBIO CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

RALLYBIO CORP - Return on Equity Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

RLYB - ROE Historical data
DateShareholders EquityNet Income Common StockReturn on Equity
6/30/2025$ 45.96M$ -41.65M-90.62%
3/31/2025$ 54.07M$ -48.19M-89.11%
12/31/2024$ 61.65M$ -57.77M-93.71%
9/30/2024$ 70.82M$ -66.97M-94.57%
6/30/2024$ 80.02M$ -73.88M-92.33%
3/31/2024$ 89.16M$ -76.28M-85.55%
12/31/2023$ 106.18M$ -74.56M-70.22%
9/30/2023$ 123.58M$ -70.53M-57.07%
6/30/2023$ 139.26M$ -70.52M-50.64%
3/31/2023$ 155.2M$ -69.47M-44.77%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • RALLYBIO CORP's latest trailing twelve months (TTM) ROE stands at 0%.
  • Over the past 5 years, RALLYBIO CORP's average ROE has been -63.26%.
  • The median ROE for RALLYBIO CORP during this period was -57.07%
  • RALLYBIO CORP reached its highest ROE over the past 5 years at -26.77%.
  • The lowest ROE recorded by RALLYBIO CORP in the same timeframe -94.57%

RALLYBIO CORP's ROE vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

ROE Benchmarks
CompanyROE
ICU : SEASTAR MEDICAL HOLDING CORP -439.12%LEXX : LEXARIA BIOSCIENCE CORP -205.16%LYRA : LYRA THERAPEUTICS INC -2394.33%LSTA : LISATA THERAPEUTICS INC -89.99%SONN : SONNET BIOTHERAPEUTICS HOLDINGS INC -PULM : PULMATRIX INC -141.51%APRE : APREA THERAPEUTICS INC -103.25%BRTX : BIORESTORATIVE THERAPIES INC -221.32%IBIO : IBIO INC -123.5%ERNA : ERNEXA THERAPEUTICS INC -983.8%

Definition of Return on Equity

[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].
Net Inc. Cmn. / Equity
(=) ROE
ROE for RALLYBIO CORP is calculated as follows: Net Inc. Cmn. [ $ -26.45M ] / Equity [ $ -46.02M ]
(=) ROE [ 0% ]

RLYB - Return on Equity, Last 5 years

-94.57%

Minimum

Sep 30, 2024

-26.77%

Maximum

Dec 31, 2021

-63.26%

Average

-57.07%

Median

ROE Benchmark Analysis

The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.63% with a standard deviation of 22.52%.
The following table provides additional summary stats:
ROE in the Market:
filtered constituents3.13K
min-66.24%
max73.25%
average1.63%
median6.53%
std22.52%